Clinical Evaluation of Panchavaktra Ras in the Management of Amavata (Rheumatoid Arthritis)
DOI:
https://doi.org/10.47552/ijam.v3i1.151Keywords:
Panchavaktra Ras, Herbo-mineral formulation, Amavata, Rheumatoid ArthritisAbstract
Objectives: This study was conducted to evaluate the effectiveness of Panchavaktra Ras in the Management of Amavata (Rheumatoid Arthritis). Materials and Methods: A single blind clinical trial was conducted at Dr. Achanta Lakshmipati Govt. Ayurvedic Hospital, M.G. Road, Vijayawada. 50 patients were selected and trial drug was advocated in a dose of 300 mg. (2 tablets) twice a day with Trikatu and Arka moola twak kashaya as anupana. Treatment was given for 45 days with the result assessment recorded at every 15 days. Subjective and objective parameters were analyzed before and after the treatment. In subjective parameters Sandhi Shula, Jadya, Angamarda, Alasya, Agnimandhya and Vidvibandha are taken, while Sandhi Shotha, Erythrocyte Sedimentation Rate (ESR) and R.A. Factor are considered as objective parameters. Results: It was observed that 48% were in mild relief group, while 50% were of moderate relief and there was Good relief in 2% of patients. Both Subjective and Objective parameters have been analyzed statistically. The relief of Sandhi Shula, Stabdata, Angimandya, Angamarda, Alasya and Vidvibandha found highly significant (P < 0.001) and same results in reduction Sandhi Shotha, ESR levels and RA Factor. Conclusion: Panchavaktra Ras prepared as per the textual standards is highly effective in Amavata and showing a way out to the individual suffering from this chronic disease. The study confirmed the effect of trial drug in Amavata (Rheumatoid arthritis) in improving the quality of life of patients without any untoward effectsPublished
How to Cite
Issue
Section
License
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.
